Has Scott Silvestry, MD received payments from drug or device companies?

Yes. Drug and device makers reported $661,208 in general payments to Scott Silvestry, MD across 533 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Silvestry, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Silvestry, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Silvestry, MD

Transplant Surgery · Orlando, FLNPI 1922028547

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (57.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Abiomed accounts for 75.5% of it on its own, with 21 other manufacturers making up the rest. Among transplant surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$661,208in general payments, 2019–2025

Across 533 payments — averaging $1240.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$499K
Abbott$102K
Medtronic$38K
Fresenius USA Marketing, Inc.$8K
Maquet Cardiopulmonary GmbH$8K
Davol Inc.$2K
plus $3K from 16 others

$400,097in research payments, 2019–2025

Across 116 payments — averaging $3449.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$269K
Transmedics, Inc.$87K
Medtronic$45K

What the payments were for

Consulting fees$150,15823%
Speaking & faculty fees$378,67557%
Travel & lodging$113,13317%
Food & beverage$18,6753%
Education$5670%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	263	$499,021
Abbott	149	$102,446
Medtronic(2 entities)	53	$38,137
Fresenius USA Marketing, Inc.	13	$8,403
Maquet Cardiopulmonary GmbH	4	$8,092
Davol Inc.	2	$2,082
Getinge USA Sales, LLC	19	$797
Edwards Lifesciences	7	$672
Cvrx, Inc.	4	$480
Inari Medical, Inc.	2	$325
Livanova USA, Inc.	2	$124
Johnson & Johnson	2	$113
Nxstage Medical, Inc.	1	$110
Arthrex	1	$108
Atricure, Inc.	2	$80
Bolton Medical Inc	2	$77
La Jolla Pharmaceutical Company	2	$41
Tetraphase Pharmaceuticals, Inc.	1	$30
Artivion, Inc.	1	$25
Pfizer	1	$16
Stryker	1	$15
Kls-martin L.p.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$410,292
HeartMate 3 Left Ventricular Dev$44,443
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$29,881
HeartWare HVAD$24,886
CARDIOMEMS$16,897
HLS Set$8,092
CardioMEMS HF System$5,700
HeartMate 3 Left Ventricular Assist Device$2,461
HeartMate Touch$759
Barostim Neo System$433
SAPIEN 3 Ultra RESILIA$370
FLOWTRIEVER CATHETER, S$325
CT THROMBECTOMY SYSTEM KIT$325
CARDIOHELP$229
Cardiovascular- Research only$199
Penditure$179
2ND GEN CENTRIMAG PRIMARY CONSOLE$168
Avalus$138
CentriMag$115
NOVALUNG SYSTEM$110

How this compares

$661,208 in reported general payments places this provider in the 95th percentile of 53 transplant surgery providers in Florida.

See all transplant surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$42,540

Medicare patients

Services billed

105

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in Orlando

Lawrence ChinOrlando$12K
Bobby NibhanupudyOrlando$3K
Michael AngelisOrlando$2K
Amy LuTampa$133K
Eduardo AlsinaTampa$121K
Kiran DhanireddyTampa$40K
Vijay SubramanianTampa$22K
Alfred TectorMiami$19K
Nicole LooJacksonville$17K
Wen XiePensacola$16K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →